Advertisement

Topics

Companies Related to "Loss Disabled Expression Pancreatic Cancer Progression" [Most Relevant Company Matches] RSS

05:07 EDT 16th June 2019 | BioPortfolio

Here are the most relevant search results for "Loss Disabled Expression Pancreatic Cancer Progression" found in our extensive corporate database of over 50,000 company records.

Showing "Loss Disabled Expression Pancreatic Cancer Progression" Companies 1–25 of 3,100+

Extremely Relevant

World Pancreatic Cancer Coalition

The World Pancreatic Cancer Coalition is an international group of pancreatic cancer patient advocacy groups with a mission to drive transformational change for all those affected by the disease. Through global collaboration, the coalition raises awareness of pancreatic cancer by strengthening the efforts of participating member organizations. Each Novembe...


Pancreatic Cancer Action

About Pancreatic Cancer Action: 5 year survival rates for pancreatic cancer have not changed in over 40 years and it is our mission to change this by way of increased awareness of pancreatic cancer within the general population, the medical community and the Government. We are developing educational programmes for trainee General Practitioners and are working on creating free Online Interactive...

Relevant

Sky Foundation, Inc.

After being diagnosed with pancreatic cancer in 2007 and responding well to treatment, Kasselman established Sky Foundation to fund research for the Sky Foundation Pancreatic Cancer Research Fund at the Barbara Ann Karmanos Cancer Institute to develop a diagnostic tool for the early detection of pancreatic cancer.


Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization raises money for direct private funding of research -- and advocates for more aggressive federal research funding of medical breakthroughs in prevention, diagnosis and treatment of pancreatic canc...

Disabled American Veterans

The 1.2 million-member Disabled American Veterans, a non-profit organization founded in 1920 and chartered by the U.S. Congress in 1932, represents this nation's disabled veterans. It is dedicated to a single purpose: building better lives for our nation's disabled veterans and their families. More information is available at www.dav.org.

The Lustgarten Foundation

The Lustgarten Foundation, based in Bethpage, New York, is America's largest private foundation dedicated solely to funding pancreatic cancer research. Founded in 1998, the Foundation provides critical support in the search for better diagnostics and treatment of pancreatic cancer, and to date has provided more than $32 million to more than 115 research projects at 41 medical and research centers ...

Agensys

Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets. The Company has discovered and validated a rich portfolio of novel, clinically relevant cancer targets to 14 different cancer types that have been carefully selected to enable development of new effective therapeutics with fewer and less ...

Kenner Family Research Fund

Kenner Family Research Fund (KFRF) was formed by family and friends of Peter Kenner, who died shortly after his diagnosis of neuroendocrine pancreatic cancer. KFRF (a fund of JCF, a registered 501(c)3 organization) is committed to the development of an early detection protocol for pancreatic cancer that will be used by primary care physicians (www.kennerfa...

The Lustgarten Foundation for Pancreatic Cancer Research

Founded in 1998 by Cablevision executive Marc Lustgarten, with Cablevision chairman Charles Dolan and CEO James Dolan, The Lustgarten Foundation is the nation's largest private, non-profit supporter of pancreatic cancer research, providing more than $20 million to date. The Foundation provides patient information and manages a national public awareness campaign. To learn more and to see Dr. Pa...

Propanc Biopharma, Inc.

Propanc Biopharma, Inc. (the "Company") is a biopharmaceutical company developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a formulation of anti-cancer compounds, which exert a number of effects designed to control or prevent tumors from recurring and spreading through...

Genomic Expression, Inc.

Genomic Expression’s mission is to save lives and to make the delivery of healthcare more effective. The inconvenient truth is that only one out of four cancer treatments prolong life. Genomic Expression aims to change this by helping doctors select the best drug for their patients, by leveraging it’s clinically focused RNA sequencing technology called ...

GTx, Inc.

GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways for the treatment and prevention of cancer, the treatment of side effects of anticancer therapy, cancer supportive care, and other serious medical conditions. ...

GTx, Inc. and Ipsen

GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways to prevent and treat cancer, fractures and bone loss, muscle loss and other serious medical conditions. For more information on GTx, visit our website, www.gtxinc.com....

Red Mountain Weight Loss

Since 1995, Red Mountain Weight Loss has become the leader in non-surgical methods of sustainable medical weight loss, providing expert care under the direction of bariatric physicians. Founded by Dr. Suzanne Bentz, board-certified in obesity medicine and weight management, Red Mountain Weight Loss has provided professional care for tens of thousands o...

Oxford Expression Technologies

Oxford Expression Technologies is a world-renowned centre of excellence for baculovirus protein expression. We provide protein expression products, services and consultancy to many global pharmaceutical companies and are now marketing commercial products based upon our world-beating flashBAC protein expression technologyOET was founded in 2000 by leading members of the School of Biological and Mol...

IntraPace, Inc.

IntraPace was founded in 2001 to address an unmet need in weight loss surgery by developing a gentler solution for weight loss that incorporates essential components of behavior therapy. The abiliti system is intended to enable patients to achieve and sustain significant weight loss without the complications, lifestyle restrictions and substantial anatomic...

QuicStick

QuicStick is leading producer of mobility products serving disabled drivers. The company’s suite of products focuses on providing disabled drivers with the independence to get out and enjoy life. QuicStick uses the only finest materials and craftsmanship in their products and provides the most competitive price points across their product lines. To le...

The Pet Loss Center

Founded in 2015, The Pet Loss Center offers pet memorial services including cremation, memorialization, ritual options and pet grief support to pet parents and veterinary clinics at their locations in Dallas and Austin, Texas. The Pet Loss Center is open Monday through Friday from 9 a.m. to 5 p.m. and Saturday 9 a.m. to 12 p.m. The Pet Loss Center also own...

Thinique Medical Weight Loss

Founded in February 2013, Thinique Medical Weight Loss is a physician-supervised weight loss medical franchise that caters to men and women who want to lose weight and transition to a healthier lifestyle. The program was designed by experts in medicine, nutrition, fitness and education. Patients are prescribed weight loss plans based on their goals, their ...

AmpliMed Corporation

AmpliMed Corporation develops novel drugs for the treatment of cancer. Our lead product, Amplimexon™ (imexon inj.), has particular promise for the treatment of pancreatic cancer, malignant melanoma, lung cancer and multiple myeloma. Other products in our portfolio have promise in ovarian, breast, prostate and other common cancers. Our compounds have novel ways of killing cancer cells which are d...

Agendia BV

Agendia, located in Amsterdam, The Netherlands, is a world leader in gene expression analysis-based diagnostics with three products on the market. The company focuses on the development and commercialization of diagnostic tests using tumor gene expression profiling. Agendia was the first company to commercialize a prognostic test -- MammaPrint(R) -- that predicts the risk of breast cancer rec...

Orpheris

Orpheris is a clinical stage neuroscience company leveraging a novel platform technology from Johns Hopkins that enables the selective delivery of therapeutic agents across the blood barrier into reactive microglial cells. In a number of neurodegenerative diseases such as ALS, Parkinson's, and Alzheimer's, reactive microglia are shown to be responsible for...

Hearing Loss Association of America

The Hearing Loss Association of America (HLAA), founded in 1979, opens the world of communication to people with hearing loss through information, education, advocacy and support. In addition to the Walk4Hearing program, HLAA publishes the bimonthly Hearing Loss Magazine, holds annual conventions (Convention 2013 is June 27-30 in Portland, OR), advocates f...

PharmaEngine Inc.

PharmaEngine, Inc. is a biopharmaceutical company established in Taipei, Taiwan in 2003. PharmaEngine focuses on the development of new treatments for cancer and Asian prevalent diseases. Besides PEP503 (NBTXR3), PharmaEngine has two other projects: PEP02 (MM-398), a nanoliposomal irinotecan for the treatment of metastatic pancreatic cancer, which was lice...

Targovax

Targovax was started in October 2010 to develop TG01, a vaccine targeting pancreatic cancer. TG01 is based on research from The Radium Hospital and Norsk Hydro in the end of the 90’s. The drug has already been tested in patients, and the company is building on these results. The company is based in Lysaker close to Oslo, Norway, and co-located with Os...


More From BioPortfolio on "Loss Disabled Expression Pancreatic Cancer Progression"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks